74 results
8-K
EX-99.1
MBOT
Microbot Medical Inc
17 Oct 23
Microbot Medical Announces Successful Initial Outcomes from Its Pivotal Pre-Clinical Study with the LIBERTY® Robotic Surgical System
9:09am
A total of 48 animal targets were reached with 100% usability and technical success and no visual acute intra-operative adverse events or complications … by three leading interventional radiologists that utilized the LIBERTY Robotic Surgical System to reach a total of 48 animal targets. A total of 6 LIBERTY
8-K
EX-99.1
MBOT
Microbot Medical Inc
31 Oct 23
Regulation FD Disclosure
8:25am
three days after the procedures using the LIBERTY Robotic Surgical System, confirms 100% success rate in reaching the targets with no adverse events … animal targets. In a series of visual testing, preformed 72 hours following each procedure, examination of the animals treated with the LIBERTY Robotic
8-K
EX-99.1
MBOT
Microbot Medical Inc
13 Oct 22
Microbot Medical Completes GLP Animal Study for the LIBERTY® Robotic System
9:34am
navigation was successfully completed for 58 out of the 63 targets (92%), while 3 of the targets (4.8%) were not completed due to technical issues … colleagues quickly adapt to performing the procedures robotically, and their success in hitting the targets is a testament to just how accessible LIBERTY
8-K
MBOT
Microbot Medical Inc
17 Oct 23
Microbot Medical Announces Successful Initial Outcomes from Its Pivotal Pre-Clinical Study with the LIBERTY® Robotic Surgical System
9:09am
radiologists that utilized the LIBERTY Robotic Surgical System to reach a total of 48 animal targets. A total of 6 LIBERTY Systems were used … in the study, and each was used to reach a total of 8 targets. All 6 LIBERTY Systems performed flawlessly, with 100% usability and technical success. No acute
8-K
sde3 6y64am4y4
31 Oct 23
Regulation FD Disclosure
8:25am
8-K
EX-99.1
xw0edc8llwcgrvm glyw
22 May 23
Microbot Medical Achieved 100% Success Rate for LIBERTY in Extensive Pre-Clinical Animal Study Performed by Leading European Physicians
8:30am
8-K
j82qcb
13 Oct 22
Microbot Medical Completes GLP Animal Study for the LIBERTY® Robotic System
9:34am
8-K
EX-99.1
5o9picugbstjwsi09q6
1 Mar 19
Other Events
5:30pm
8-K
EX-99.1
qx52w xiimvfkehwhho
3 May 23
Regulation FD Disclosure
9:00am
8-K
ton22o0sxpje9rjosbr
1 Mar 19
Other Events
5:30pm
8-K
7o3iu wqd0pkn7ym7mer
3 May 23
Regulation FD Disclosure
9:00am
8-K
4dl15 1v1
29 Jun 23
Microbot Medical Successfully Completes an Extensive Pre-Clinical Study Performed in the US
8:30am
8-K
EX-99.1
gqbg9utg109y92n882
29 Jun 23
Microbot Medical Successfully Completes an Extensive Pre-Clinical Study Performed in the US
8:30am
8-K
z3hcfllgk1
22 May 23
Microbot Medical Achieved 100% Success Rate for LIBERTY in Extensive Pre-Clinical Animal Study Performed by Leading European Physicians
8:30am
8-K
nx9n199qug5hs
6 Apr 22
Microbot Medical Continues to Strengthen Management Team as Rachel Vaknin Promoted to Chief Financial Officer
4:05pm
8-K
EX-99.1
8ftfxnd1c0b 8m4o
11 Feb 10
Stemcells, Inc. Announces First Human Neural Stem Cell Transplant In Landmark Myelination Disorder Trial
12:00am